435 S



215 E. Prospect Ave.

Pierre, SD 57501

E-Mail:

BQA Coordinator

Phone: 605-224-2333
Fax: 605-224-0224

Back to Exam home page

Back to BQA/CMP main page

Design by BPro

 
     
 

Section 5 - Individual Treatments Background Information


 
 

An effective health plan should be a part of every feeder or producer’s program.  However, even the best preventive program will not eliminate the need for at least occasional individual treatments.  It is here that a residue problem is most likely to occur.   Consult your veterinarian in developing or changing treatment regimes to eliminate the chance of residue occurrence.

In the industry’s efforts to prevent violative drug residues, it is essential to comply with label directions for administration and withdrawal times.  Any deviation from label directions requires a veterinarian’s prescription and compliance with additional precautionary steps discussed later in this section.  The Withdrawal Time Chart sets forth a list of most FDA approved medications used for individual treatments.  This list is for reference only as label directions can provide complete instructions that should be followed when administering any drug.  If you have any questions regarding the use of specific drugs, consult your veterinarian.

Use of a medication other than in strict compliance with label directions, including use in species or for indications not listed on the label, or used at dosage levels higher than those stated on the label and failure to observe the stated withdrawal time is commonly referred to as "extra label drug usage."  It is in this area that you are most likely to encounter violative drug residue problems.  The Center for Veterinary Medicine (CVM), a division of the FDA, has revised its policies concerning extra label drug use.  For such usage, the CVM of the FDA specifies that the following criteria must be met.

1.     A careful diagnosis is made by an attending veterinarian within the context of a valid veterinarian-client-patient relationship.  (Section 9)

2.     A determination is made that: (a) there is no marketable drug specifically labeled to treat the condition diagnosed, or (b) treatment at the dosage recommended by the labeling was found clinically ineffective.

3.     Procedures are instituted to assure that identity of the treated animal is carefully  maintained.

4.     A significantly extended period of time is assigned for drug withdrawal prior to marketing of the treated animal, steps are taken to assure the assigned time frames are met and no harmful residue occurs.

The issue of drug withdrawal for extra label drug use is unclear at best.  A veterinarian is the only one who can determine the withdrawal time for a drug used extra label or across species.  These time periods must be based on the veterinarian’s professional judgment of the drug action and the conditions for which the drug is administered.  Because the role of the veterinarian is so critical in extra label drug usage, the CVM has established guidelines to determine when a veterinarian-client-patient relationship exists.  These criteria are:

1.    The veterinarian has assumed the responsibility for making clinical judgments regarding the health of the animal and the need for medical treatment, and the client has agreed to follow the veterinarian’s instructions.

2.    The veterinarian has sufficient knowledge of the animal to initiate at least a general or preliminary diagnosis of the medical condition of the animal.  This means the veterinarian has seen and is personally acquainted with the keeping and care of the animal by virtue of examination of the animal or by medically appropriate and timely visits to the premises where the animal is being kept.

3.    The veterinarian is readily available for follow up evaluation in the event of adverse reactions or failure of a treatment regimen.

The veterinarian must make a professional judgment as to the withdrawal time required for a drug used extra label.  The participant must maintain proper records to demonstrate that the veterinarian’s prescription instructions have been followed.

It is only through proper records that you can hope to establish liability with the proper party for a residue contamination.  The recordkeeping systems at the end of this section were developed from systems that are working well for many facilities.  If you have a system that is working for you and accomplishes the same results, there is no need for change.  However, if your system is not adequate, the examples at the end of this section will provide ideas to develop a system that will work for you.

Back to Section 5         Back     Continue